Companies / Ionis Pharmaceuticals Inc / Activity
Activity — Ionis Pharmaceuticals Inc
251 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Kordasiewicz Holly B. Executive | Exercise | Common Stock | $0 | +11K +143.66% | 18,859 0.01% of shares | low |
| Jan 15, 2026 | Devers Shannon L. Executive | Exercise | Common Stock | $0 | +17K +99.33% | 34,871 0.02% of shares | low |
| Jan 29, 2026 | Birchler Brian Executive | Grant | Common Stock | $0 | +12K +19.84% | 72,426 0.04% of shares | low |
| Jan 15, 2026 | Birchler Brian Executive | Exercise | Common Stock | $0 | +20K +41.14% | 68,915 0.04% of shares | low |
| Jan 29, 2026 | Schneider Eugene Executive | Grant | Common Stock | $0 | +12K +18.77% | 75,881 0.05% of shares | low |
| Jan 15, 2026 | Schneider Eugene Executive | Exercise | Common Stock | $0 | +22K +42.10% | 73,192 0.04% of shares | low |
| Jan 29, 2026 | Baroldi Joseph Executive | Grant | Common Stock | $0 | +10K +25.42% | 50,709 0.03% of shares | low |
| Jan 15, 2026 | Baroldi Joseph Executive | Exercise | Common Stock | $0 | +3K +92.80% | 5,921 <0.01% of shares | low |
| Jan 15, 2026 | Baroldi Joseph Executive | Exercise | Common Stock | $0 | +17K +56.23% | 47,338 0.03% of shares | low |
| Jan 15, 2026 | Jenne Kyle Executive | Exercise | Common Stock | $0 | +7K +62.62% | 18,212 0.01% of shares | low |
| Jan 29, 2026 | Swayze Eric Executive | Grant | Common Stock | $0 | +12K +28.59% | 53,926 0.03% of shares | low |
| Jan 15, 2026 | Swayze Eric Executive | Exercise | Common Stock | $0 | +111 +43.36% | 367 <0.01% of shares | low |
| Jan 15, 2026 | Swayze Eric Executive | Exercise | Common Stock | $0 | +21K +70.16% | 51,819 0.03% of shares | low |
| Jan 15, 2026 | Yang Michael J. Director | Exercise | Common Stock | $0 | +2K +32.11% | 7,940 <0.01% of shares | low |
| Jan 29, 2026 | O'Neil Patrick R. Executive | Grant | Common Stock | $0 | +12K +18.12% | 78,162 0.05% of shares | low |
| Jan 15, 2026 | O'Neil Patrick R. Executive | Exercise | Common Stock | $0 | +21K +39.85% | 75,362 0.05% of shares | low |
| Jan 29, 2026 | Monia Brett P CEO | Grant | Common Stock | $0 | +122K +54.39% | 346,897 0.21% of shares | low |
| Jan 15, 2026 | Monia Brett P CEO | Exercise | Common Stock | $0 | +89K +49.64% | 268,717 0.16% of shares | low |
| Jan 29, 2026 | Hougen Elizabeth L Executive | Grant | Common Stock | $0 | +14K +10.74% | 139,869 0.08% of shares | low |
| Jan 15, 2026 | Hougen Elizabeth L Executive | Exercise | Common Stock | $0 | +29K +26.00% | 139,229 0.08% of shares | low |
| Jan 29, 2026 | Bennett C Frank Executive | Grant | Common Stock | $0 | +11K +12.05% | 106,178 0.06% of shares | low |
| Jan 15, 2026 | Bennett C Frank Executive | Exercise | Common Stock | $0 | +21K +25.47% | 103,734 0.06% of shares | low |
| Feb 2, 2026 | Bennett C Frank Executive | Other | Common Stock | $0 | 0 0.00% | 100,293 0.06% of shares | low |
| Mar 3, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $2.9K | -36 -0.82% | 4,347 <0.01% of shares | low |
| Jan 16, 2026 | Swayze Eric Executive | Sell | Common Stock | $3.7K | -49 -13.35% | 318 <0.01% of shares | low |
| Mar 4, 2026 | Baroldi Joseph Executive | Exercise | Common Stock | $6.6K | +201 +4.62% | 4,548 <0.01% of shares | low |
| Mar 4, 2026 | Loscalzo Joseph Director | Exercise | Common Stock | $7.6K | +200 +0.55% | 36,530 0.02% of shares | low |
| Feb 27, 2026 | Swayze Eric Executive | Other | Common Stock | $12.5K | +256 +0.80% | 32,361 0.02% of shares | low |
| Feb 27, 2026 | Bennett C Frank Executive | Other | Common Stock | $12.8K | +261 +0.26% | 100,554 0.06% of shares | low |
| Mar 4, 2026 | Baroldi Joseph Executive | Exercise | Common Stock | $13.5K | +238 +5.47% | 4,585 <0.01% of shares | low |
| Mar 4, 2026 | Loscalzo Joseph Director | Sell | Common Stock | $16.0K | -200 -0.55% | 36,330 0.02% of shares | low |
| Mar 4, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $16.1K | -201 -4.42% | 4,347 <0.01% of shares | low |
| Feb 27, 2026 | Birchler Brian Executive | Other | Common Stock | $17.2K | +351 +0.53% | 66,598 0.04% of shares | low |
| Feb 27, 2026 | O'Neil Patrick R. Executive | Other | Common Stock | $18.4K | +376 +0.52% | 72,359 0.04% of shares | low |
| Mar 4, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $19.0K | -238 -5.19% | 4,347 <0.01% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Exercise | Common Stock | $20.4K | +385 +0.91% | 42,647 0.03% of shares | low |
| Feb 27, 2026 | Monia Brett P CEO | Other | Common Stock | $23.7K | +484 +0.19% | 254,981 0.15% of shares | low |
| Mar 3, 2026 | Baroldi Joseph Executive | Exercise | Common Stock | $28.7K | +879 +15.72% | 6,471 <0.01% of shares | low |
| Mar 3, 2026 | Loscalzo Joseph Director | Exercise | Common Stock | $31.7K | +832 +2.29% | 37,162 0.02% of shares | low |
| Apr 15, 2026 | Parshall B Lynne Director | Sell | Common Stock | $41.1K | -534 -1.03% | 51,344 0.03% of shares | low |
| Mar 3, 2026 | Baroldi Joseph Executive | Exercise | Common Stock | $46.6K | +820 +17.18% | 5,592 <0.01% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $61.0K | -755 -3.24% | 22,541 0.01% of shares | low |
| Mar 3, 2026 | Bennett C Frank Executive | Sell | Common Stock | $64.8K | -802 -0.99% | 80,554 0.05% of shares | low |
| Mar 3, 2026 | Loscalzo Joseph Director | Sell | Common Stock | $66.8K | -832 -2.24% | 36,330 0.02% of shares | low |
| Jan 7, 2026 | Devers Shannon L. Executive | Exercise | Common Stock | $68.5K | +2K +12.01% | 19,595 0.01% of shares | low |
| Mar 3, 2026 | Diaz Allene M. Director | Sell | Common Stock | $81.2K | -1K -20.87% | 3,811 <0.01% of shares | low |
| Mar 3, 2026 | Klein Joseph III Director | Sell | Common Stock | $81.8K | -1K -8.42% | 11,014 <0.01% of shares | low |
| Jan 16, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $87.1K | -1K -19.41% | 4,772 <0.01% of shares | low |
| May 1, 2026 | Klein Joseph III Director | Sell | Common Stock | $106.5K | -1K -11.50% | 11,014 <0.01% of shares | medium |
| Jan 7, 2026 | Devers Shannon L. Executive | Exercise | Common Stock | $112.8K | +3K +19.78% | 20,954 0.01% of shares | low |